The researchers believe that “Better understanding of the causes and consequences of apathy and its role in the clinical progression of FTD is vital to develop effective treatment strategies, including preventive strategies.”
In a study, only androgen deprivation therapy with oral antiandrogens were associated with an increased risk for dementia and Alzheimer disease.
The US mortality burden associated with dementia may be underestimated by vital statistics.
Patients with dementia are frequently prescribed central nervous system-active medications.
Reversing recent trends, baby boomers are showing lower cognitive functioning as they age than previous generations.
MRI-based cerebrovascular reactivity is associated with cognitive function independent of Alzheimer disease pathology.
Early sleep fragmentation, estimated by actigraphy, was found to be associated with worse cognitive impairment shortly after critical illness.
The FDA has accepted for Priority Review the Biologics License Application for aducanumab (Biogen) for the treatment of Alzheimer disease.
The Lancet Commission added 3 new risk factors for dementia that coupled with the previous 9 lifestyle risk factors might prevent or delay up to 40% of dementias worldwide.
The COVID-19 pandemic is having an impact on the psychological health of patients with relapsing-remitting multiple sclerosis.
